After Hours
$
55.36
Change
+2.63 +4.99%
Volume
Volume 51,279
Jan 31, 2023, 5:03 p.m.
Quotes are delayed by 20 min
Today's close
$ 52.74
$ 52.73
Change
-0.01 -0.02%
Day low
Day high
$52.32
$53.34

52 week low
52 week high
$33.32
$70.00

Market cap
$5.83B
Average volume
1.13M
P/E ratio
N/A
Rev. per Employee
$237,498
EPS
-6.24
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on APLS
-
Is pharma M&A making a comeback?
- Jaimy Lee
-
10 Stocks Driving the Biotech Resurgence
- Barron's Online
-
Apellis Pharmaceuticals Stock Jumps After FDA Accepts Drug for Review
- Barron's Online
-
4 Midsize Biotech Stocks That Have Breakout Potential
- Barron's Online
-
Apellis Stock Plunges After Its Eye Treatment Gets Mixed Results
- Barron's Online
-
Apellis Pharmaceuticals downgraded to neutral from outperform at Wedbush
- Tomi Kilgore
-
Apellis stock price target cut to $57 from $101 at J.P. Morgan
- Tomi Kilgore
-
Apellis Pharmaceuticals upgraded to outperform from neutral at Wedbush
- Tomi Kilgore
-
Apellis Pharmaceuticals price target raised to $104 from $78, stock rated strong buy
- Tonya Garcia
-
Bull trend pauses: U.S. benchmarks digest rally to latest record close
- Michael Ashbaugh
-
Apellis stock price target raised to $87 from $50 at J.P. Morgan
- Tomi Kilgore
-
Apellis Pharmaceuticals started at buy with $40 stock price target at Stifel Nicolaus
- Tomi Kilgore
-
21 Risky Stocks That Might Have Borrowed Too Much
- Barron's Online
- Loading more headlines...
Analyst Ratings
-
Benzinga's Top Upgrades, Downgrades For February 8, 2018
- Benzinga.com
Other News on APLS
-
10-Q: APELLIS PHARMACEUTICALS, INC.
- Edgar Online - (EDG = 10Q, 10K)
-
Notable earnings after Monday's close
- Seeking Alpha
-
Apellis Pharmaceuticals Q3 2022 Earnings Preview
- Seeking Alpha
-
LogicBio jumps 648% on buyout deal with AstraZeneca unit Alexion
- Seeking Alpha
- Loading more headlines...
Press Releases on APLS
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com